Forskningsprosjekter

Foto: Hans Fredrik Asbjørnsen

Denne oversikten inneholder alle prosjekter ved Farmasøytisk institutt som har en presentasjon på nett.

• A
  • ACCESS – vACcine Covid-19 monitoring ReadinESS
  • Antimicrobial resistance

• B
  • Bacillus cereus genome dynamics - unravelling novel principle virulence mechanisms in pathogenic spore-forming bacteria
  • Bacterial Extracellular Membrane Vesicles
  • Biofilmdannelse i Gram-positive sporedannende patogene bakterier

• C
  • CONSIGN – Covid-19 infectiOn aNd medicineS In pregnancy
  • COVID-19, gravide og ammende - en internasjonal undersøkelse

• D
  • DRUG-TRIAD

• E
  • ERC Start Grant "DrugsInPregnancy"
  • EU-COVID-19 – a multinational registry-based linkage study with focus on risk and protective factors, clinical outcomes and mental health

• F
  • Fungal beta-glucan particles

• H
  • HEALTHx2: patient-centered approaches for studying the effectiveness and reproductive safety of antidepressant medication in perinatal women

• I
  • Infectious salmon anemia virus (ISAV)
  • International Alliance for PharmacoGenetic Epidemiology Excellence (iAPOGEE)

• L
  • Levocetirizine/cetirizine nivåer i brystmelk – observasjons og klinisk studie blant ammende kvinner
  • LIPIDBRAIN

• M
  • MAMP-studien: Medisinetterlevelse i svangerskapet med fokus på antidepressiva og astmamedisiner
  • Mechanistic understanding of the complex host-microbiome-drug interplay – a novel approach in optimization of immunosuppressive drug therapy
  • Medisinplanter fra Mali
  • MinSafeStart – Ny mobilapplikasjon for svangerskapskvalme
  • MinSafeStart fase 2

• N
  • Neurotoxic mechanisms of environmental chemicals and opioids on brain development
  • Nordic COllaborative HEalth REgister Network for Covid-19 Epidemiology (Nordic COHERENCE)
  • Novel disinfectant and effects on the skin microbiome

• P
  • Pre-klinisk utvikling av en ny metallo-beta-laktamase inhibitor APC148

• S
  • SafeStart - Trygg medisinbruk hos gravide
  • SafeTwoTreat
  • Synthesis of Resolvin D1 and Analogs as Potential Anti-Angiogenetic Agents
  • Synthesis, Molecular Modelling and Biological Evaluation of Protectin D1 and Analogs

• V
  • VERDI